ELOTUZUMAB | B761035 | BRISTOL MYERS SQUIBB
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Nov. 30, 2027 | Active | Computed |
| 7-Year Orphan | Nov. 6, 2025 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12384852(composition) · relevance 75/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
44 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.